Conclusion of a non-exclusive discount agreement under Section 130a(8) SGB V for the active substance Gentamicin, ATC S01AA11, for the period 1 June 2026 to 31 May 2028 (plus option to extend once by 12 months)

Summary

The tender concerns the conclusion of a non-exclusive discount agreement for medicines containing gentamicin for the period 1 June 2026 to 31 May 2028, with one possible extension of 12 months. The bidder must submit the required contract documents and note that accession is also possible later during the contract term on the same conditions.